C21H19I4NO10
Neat
953.0
+5°C
Room Temperature
21462-56-6; Thyroxine glucuronide; DTXSID001319002; RefChem:189910; DTXCID201744514; (2S, 3S, 4S, 5R)-6-(4-(4-((2S)-2-amino-2-carboxyethyl)-2, 6-diiodophenoxy)-2, 6-diiodophenoxy)-3, 4, 5-trihydroxyoxane-2-carboxylic acid; beta-D-glucopyranosiduronic acid, 4-(4-(2-amino-2-carboxyethyl)-2, 6-diiodophenoxy)-2, 6-diiodophenyl, (S)-; Thyroxine 4'-O-b-D-Glucuronide; Levothyroxine Phenolic Glucuronide; 4-[4-[(2S)-2-Amino-2-carboxyethyl]-2, 6-diiodophenoxy]-2, 6-diiodophenyl ss-D-Glucopyranosiduronic ccAcid; Levothyroxine Phenolic Glucuronide; (S)-4-[4-(2-Amino-2-carboxyethyl)-2, 6-diiodophenoxy]-2, 6-diiodophenyl ss-D-Glucopyranosiduronic Acid; L-Thyroxine Glucuronide; Thyroxine Glucuronide;; C21H19I4NO10; Thyroxine 4'-O- beta -D-Glucuronide; FT32499; Thyroxine 4 inverted exclamation mark -O-b-D-Glucuronide; (2S, 3S, 4S, 5R, 6S)-6-[4-[4-[(2S)-2-amino-2-carboxy-ethyl]-2, 6-diiodo-phenoxy]-2, 6-diiodo-phenoxy]-3, 4, 5-trihydroxy-tetrahydropyran-2-carboxylic acid; 4-[4-[(2S)-2-Amino-2-carboxyethyl]-2, 6-diiodophenoxy]-2 and 6-diiodophenyl beta-D-Glucopyranosiduronic ccAcid
(2S, 3S, 4S, 5R, 6S)-6-[4-[4-[(2S)-2-amino-2-carboxyethyl]-2, 6-diiodophenoxy]-2, 6-diiodophenoxy]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C21H19I4NO10/c22-8-1-6(3-12(26)19(30)31)2-9(23)16(8)34-7-4-10(24)17(11(25)5-7)35-21-15(29)13(27)14(28)18(36-21)20(32)33/h1-2,4-5,12-15,18,21,27-29H,3,26H2,(H,30,31)(H,32,33)/t12-,13-,14-,15+,18-,21+/m0/s1